These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29980385)

  • 1. Familial hypercholesterolemia: Experience in the Lipid Clinic of Alava.
    Pérez García L
    Clin Investig Arterioscler; 2018; 30(5):224-229. PubMed ID: 29980385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.
    Allard MD; Saeedi R; Yousefi M; Frohlich J
    Lipids Health Dis; 2014 Apr; 13():65. PubMed ID: 24712315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
    Iyen B; Qureshi N; Kai J; Akyea RK; Leonardi-Bee J; Roderick P; Humphries SE; Weng S
    Atherosclerosis; 2019 Aug; 287():8-15. PubMed ID: 31181417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.
    Béliard S; Boccara F; Cariou B; Carrié A; Collet X; Farnier M; Ferrières J; Krempf M; Peretti N; Rabès JP; Varret M; Vimont A; Charrière S; Bruckert E;
    Atherosclerosis; 2018 Oct; 277():334-340. PubMed ID: 30270068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab.
    Ridker PM; Rose LM; Kastelein JJP; Santos RD; Wei C; Revkin J; Yunis C; Tardif JC; Shear CL;
    J Clin Lipidol; 2018; 12(4):958-965. PubMed ID: 29685591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
    van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
    Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
    Perez-Calahorra S; Laclaustra M; Marco-Benedí V; Lamiquiz-Moneo I; Pedro-Botet J; Plana N; Sanchez-Hernandez RM; Amor AJ; Almagro F; Fuentes F; Suarez-Tembra M; Civeira F;
    Atherosclerosis; 2019 May; 284():245-252. PubMed ID: 30827715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
    de Isla LP; Vallejo-Vaz AJ; Watts GF; Muñiz-Grijalvo O; Alonso R; Diaz-Diaz JL; Arroyo-Olivares R; Aguado R; Argueso R; Mauri M; Romero MJ; Álvarez-Baños P; Mañas D; Cepeda JM; Gonzalez-Bustos P; Casañas M; Michan A; Muñoz-Torrero JFS; Faedo C; Barba MA; Dieguez M; de Andrés R; Hernandez AM; Gonzalez-Estrada A; Padró T; Fuentes F; Badimon L; Mata P;
    Lancet Diabetes Endocrinol; 2024 Sep; 12(9):643-652. PubMed ID: 39098315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.
    Galema-Boers AM; Lenzen MJ; Engelkes SR; Sijbrands EJ; Roeters van Lennep JE
    J Clin Lipidol; 2018; 12(2):409-416. PubMed ID: 29398430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.
    Wald DS; Bangash FA; Bestwick JP
    Eur J Intern Med; 2015 Mar; 26(2):127-30. PubMed ID: 25682442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.
    Anagnostis P; Vaitsi K; Mintziori G; Goulis DG; Mikhailidis DP
    Curr Med Res Opin; 2020 May; 36(5):731-740. PubMed ID: 32096673
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
    Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death.
    Krogh HW; Mundal L; Holven KB; Retterstøl K
    Eur Heart J; 2016 May; 37(17):1398-405. PubMed ID: 26586781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
    Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.